148 related articles for article (PubMed ID: 31788075)
1. Bioinformatics analysis of Ewing's sarcoma: Seeking key candidate genes and pathways.
Zhang J; Zhang Y; Li Z; Wu H; Xun J; Feng H
Oncol Lett; 2019 Dec; 18(6):6008-6016. PubMed ID: 31788075
[TBL] [Abstract][Full Text] [Related]
2. Slow skeletal muscle troponin T, titin and myosin light chain 3 are candidate prognostic biomarkers for Ewing's sarcoma.
Deng Y; Xie Q; Zhang G; Li S; Wu Z; Ma Z; He X; Gao Y; Wang Y; Kang X; Wang J
Oncol Lett; 2019 Dec; 18(6):6431-6442. PubMed ID: 31807166
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a novel ubiquitination-related gene
Qu G; Xu Y; Qu Y; Qiu J; Chen G; Zhao N; Deng J
Front Oncol; 2023; 13():1000949. PubMed ID: 36910645
[TBL] [Abstract][Full Text] [Related]
4. Identification of key genes and pathways in Ewing's sarcoma using bioinformatics analysis.
Yan C; Wang Y; Wang Q; Feng X; Wang L; Bu Z; Lu B; Jiang J
J BUON; 2018; 23(5):1472-1480. PubMed ID: 30570875
[TBL] [Abstract][Full Text] [Related]
5. Identification of key genes and pathways in Ewing's sarcoma patients associated with metastasis and poor prognosis.
Li G; Zhang P; Zhang W; Lei Z; He J; Meng J; Di T; Yan W
Onco Targets Ther; 2019; 12():4153-4165. PubMed ID: 31213834
[No Abstract] [Full Text] [Related]
6. Downregulated annexin A1 expression correlates with poor prognosis, metastasis, and immunosuppressive microenvironment in Ewing's sarcoma.
Shi X; Wu Y; Tang L; Ni H; Xu Y
Aging (Albany NY); 2023 Mar; 15(6):2321-2346. PubMed ID: 36988561
[TBL] [Abstract][Full Text] [Related]
7. Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma.
Liao H; Xie X; Xu Y; Huang G
Onco Targets Ther; 2018; 11():6947-6956. PubMed ID: 30410352
[TBL] [Abstract][Full Text] [Related]
8. Identification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing's Sarcoma Using Bioinformatics Analysis.
Zhang J; Huang J; Liu W; Ding L; Cheng D; Xiao H
J Immunol Res; 2022; 2022():3655908. PubMed ID: 35578666
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
Wang Y; Zhang Y; Huang Q; Li C
Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
[TBL] [Abstract][Full Text] [Related]
10. Screening of Potential Key Biomarkers for Ewing Sarcoma: Evidence from Gene Array Analysis.
Zhong D; Chen D; Zhang G; Lin S; Mei R; Yu X
Int J Gen Med; 2022; 15():2575-2588. PubMed ID: 35342299
[TBL] [Abstract][Full Text] [Related]
11. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of ICAM1 inhibits metastasis and improves the prognosis of Ewing's sarcoma.
Pan B; Bu X; Cao M; Zhang X; Huo T; Li Z; Gao X; Jing L; Luo X; Feng H; Yuan F; Guo K
J Cancer Res Clin Oncol; 2021 Feb; 147(2):393-401. PubMed ID: 33104883
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
14. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
16. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
Shi Y; Li Y; Yan C; Su H; Ying K
Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes and pathways in esophageal adenocarcinoma using bioinformatics analysis.
He F; Ai B; Tian L
Biomed Rep; 2018 Oct; 9(4):305-312. PubMed ID: 30233782
[TBL] [Abstract][Full Text] [Related]
19. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
20. Identification of key candidate genes and pathways in endometrial cancer: Evidence from bioinformatics analysis.
Lv S; Xu X; Wu Z
Oncol Lett; 2019 Dec; 18(6):6679-6689. PubMed ID: 31807178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
